Page last updated: 2024-11-06

hydroxyproline and Anti-GBM Disease

hydroxyproline has been researched along with Anti-GBM Disease in 1 studies

Hydroxyproline: A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.
hydroxyproline : A proline derivative that is proline substituted by at least one hydroxy group.

Research Excerpts

ExcerptRelevanceReference
"The hydroxyproline release assay was used to quantitate degradation of rat GBM in vitro by leukocyte proteinases stimulated by phorbol myristate acetate (PMA), in the presence or absence of EACA and aprotinin."1.31Mechanism of antinephritic effect of proteinase inhibitors in experimental anti-GBM glomerulopathy. ( Hruby, Z; Kopeć, W; Paczek, L; Soin, J; Wendycz, D; Zieliński, B, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hruby, Z1
Wendycz, D1
Kopeć, W1
Zieliński, B1
Paczek, L1
Soin, J1

Other Studies

1 other study available for hydroxyproline and Anti-GBM Disease

ArticleYear
Mechanism of antinephritic effect of proteinase inhibitors in experimental anti-GBM glomerulopathy.
    Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie, 2000, Volume: 199, Issue:5

    Topics: Aminocaproic Acid; Animals; Anti-Glomerular Basement Membrane Disease; Aprotinin; Basement Membrane;

2000